Göğüs Kalp ve Damar Cerrahisi
Ameliyat Öncesi Anemi Tedavisi ve Eritrosit Kitlesinin En İyi Duruma Getirilmesi
Ferric carboxymaltose in patients with heart failure and iron deficiency. (yeni pencere açar)
Kaynak: N Engl J Med 2009;361(25):2436-48.
İndeks: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (yeni pencere açar)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (yeni pencere açar)
Kaynak: Vasc Endovascular Surg 2007;41(5):460-2.
İndeks: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (yeni pencere açar)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (yeni pencere açar)
Kaynak: Catheter Cardiovasc Interv 2014;83(6):E221-6.
İndeks: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (yeni pencere açar)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (yeni pencere açar)
Kaynak: Anesth Analg 2019;128(5):981-92.
İndeks: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (yeni pencere açar)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (yeni pencere açar)
Kaynak: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (yeni pencere açar)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (yeni pencere açar)
Kaynak: Am J Cardiol 2012;110(7):1021-6.
İndeks: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (yeni pencere açar)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (yeni pencere açar)
Kaynak: Eur J Heart Fail 2013;15(11):1267-76.
İndeks: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (yeni pencere açar)
Current status of pharmacologic therapies in patient blood management. (yeni pencere açar)
Kaynak: Anesth Analg 2013;116(1):15-34.
İndeks: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (yeni pencere açar)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
İndeks: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (yeni pencere açar)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (yeni pencere açar)
Kaynak: Transfusion 2008;48(4):666-72.
İndeks: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (yeni pencere açar)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (yeni pencere açar)
Kaynak: Br J Anaesth. 2022;128(5):796-805.
İndeks: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (yeni pencere açar)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (yeni pencere açar)
Kaynak: Transfus Med Rev 2013;27(4):221-34.
İndeks: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (yeni pencere açar)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
İndeks: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (yeni pencere açar)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (yeni pencere açar)
Kaynak: Transfusion 2014;54(10 Pt 2):2745-52.
İndeks: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (yeni pencere açar)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
İndeks: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (yeni pencere açar)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (yeni pencere açar)
Kaynak: Surg Infect (Larchmt) 2009;10(1):9-19.
İndeks: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (yeni pencere açar)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (yeni pencere açar)
Kaynak: Anaesthesia 2020;75(8):1039-49.
İndeks: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (yeni pencere açar)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (yeni pencere açar)
Kaynak: J Vasc Surg 2003;37(2):453-5.
İndeks: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (yeni pencere açar)
Intravenous iron in heart failure: beyond targeting anemia. (yeni pencere açar)
Kaynak: Curr Heart Fail Rep 2011;8(1):14-21.
İndeks: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (yeni pencere açar)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
İndeks: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (yeni pencere açar)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (yeni pencere açar)
Kaynak: J Nephrol 2008;21(2):236-42.
İndeks: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (yeni pencere açar)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2010;139(3):621-7.
İndeks: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (yeni pencere açar)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (yeni pencere açar)
Kaynak: Transfusion 2015;55(7):1644-54.
İndeks: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (yeni pencere açar)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
İndeks: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (yeni pencere açar)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (yeni pencere açar)
Kaynak: Anesthesiology 2011;115(5):929-37.
İndeks: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (yeni pencere açar)